As of 2025-07-08, the Relative Valuation of Cara Therapeutics Inc (CARA) is (296.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -5674.7%.
The range of the Relative Valuation is (296.49) - (282.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 18.2x | 17.8x |
| Forward P/E multiples | 19.1x - 22.0x | 20.4x |
| Fair Price | (296.49) - (282.85) | (296.57) |
| Upside | -5673.2% - -5416.7% | -5674.7% |
| Date | P/E |
| 2025-05-09 | -1.65 |
| 2025-05-08 | -1.68 |
| 2025-05-07 | -1.68 |
| 2025-05-06 | -1.69 |
| 2025-05-05 | -1.79 |
| 2025-05-02 | -1.72 |
| 2025-05-01 | -1.64 |
| 2025-04-30 | -1.61 |
| 2025-04-29 | -1.48 |
| 2025-04-28 | -1.36 |
| 2025-04-25 | -1.22 |
| 2025-04-24 | -1.15 |
| 2025-04-23 | -1.19 |
| 2025-04-22 | -1.26 |
| 2025-04-21 | -1.13 |
| 2025-04-17 | -1.10 |
| 2025-04-16 | -1.18 |
| 2025-04-15 | -1.03 |
| 2025-04-14 | -1.07 |
| 2025-04-11 | -0.95 |
| 2025-04-10 | -0.94 |
| 2025-04-09 | -0.95 |
| 2025-04-08 | -0.94 |
| 2025-04-07 | -0.92 |